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Edited by Daniela RuﬀellAbstract The spliceosome is a dynamic, macromolecular com-
plex, which removes non-protein-coding introns from pre-mRNA
to form mature mRNA in a process known as splicing. This ribo-
nucleoprotein assembly is comprised of ﬁve uridine-rich small nu-
clear RNAs (snRNAs) as well as over 300 proteins. In humans,
several of the known proteinaceous splicing factors are members
of the immunophilin superfamily. Immunophilins are peptidyl-
prolyl cis–trans isomerases that catalyze the conversion of pro-
teins from cis to trans at Xaa-Pro bonds. Our review of the data
indicates that some members of this protein family are activators
of spliceosomal proteins by way of folding and transport.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Most of the transcripts produced in the eukaryotic cell are
comprised of both protein-coding exons and non-protein-cod-
ing introns. Following transcription, the introns are removed
and the exons ligated together by a dynamic, high molecular
weight RNA–protein complex known as the spliceosome [1].
This macromolecular complex is composed of ﬁve uridine-rich
small nuclear RNAs (snRNAs) designated U1, U2, U4, U5
and U6 each bound to a core set of snRNA-speciﬁc proteins
as well as numerous other proteinaceous splicing factors which
form small nuclear ribonucleoprotein particles (SnRNPs) [2,3].
Some of these proteins are an essential part of the spliceosome
while others perform auxiliary roles in the processing of tissue-
and/or developmental stage-speciﬁc transcripts.
The snRNAs form distinct stem-loop structures that facili-
tate snRNA-protein and snRNA pre-mRNA interactions [4].
The mechanism of splicing involves a cascade of assembly,
trans-esteriﬁcation and disassembly reactions to produce two
ligated exons and an excised intron, which is subsequently de-
graded [5] (see Fig. 1 for a diagrammatic representation of the
pre-mRNA splicing process). Following transcription of the
pre-mRNA, the U1 small nuclear ribonucleoprotein particle
(snRNP) binds to the 5 0 exon–intron junction in an ATP inde-*Corresponding author. Fax: +1 305 349 1259.
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doi:10.1016/j.febslet.2008.06.006pendent reaction, creating the E complex [6] (Fig. 1). The U1
snRNP promotes the association of U2 with the branch point
intronic sequence in an ATP-dependent manner (the A com-
plex) [7], establishing a favorable conformation for the ﬁrst
trans-esteriﬁcation reaction [8,9] (Fig. 1). Next, a tri-snRNP
composed of the U4/U6 di-snRNP and the U5 snRNP interact
with the U2 snRNP to produce the B1 complex [10] (Fig. 1).
The ﬁrst trans-esteriﬁcation reaction takes place in the B2 com-
plex, creating a free 5 0 exon and a lariat intron/3 0 exon [11]
(Fig. 1). The C1 spliceosome is responsible for the second
trans-esteriﬁcation, where the 3 0 end of the intron is truncated,
separating the intron from the 3 0 exon. At this time, the U5
snRNP holds the two exons in close proximity [9]. Finally,
C2 is formed by two ligated exons, an independent lariat
intron as well as the U2, U5 and U6 snRNPs [12] (Fig. 1).
Subsequent to production of the ligated exons, the U2/
U6.U5 tri-snRNP complex disassembles into individual
snRNPs and are recycled in preparation for the next round
of splicing [13] (Fig. 1).
In mammalian systems, over 300 proteins participate in
splicing, making the spliceosome one of the largest cellular
complexes discovered thus far [14,15]. Many of these proteins
have been previously identiﬁed and participate in a variety of
additional cellular processes including transcription regula-
tion, intra- and inter-cellular transport, apoptosis, kinase
activity and protein folding (Fig. 2). Proteomics analyses of
the human spliceosome identiﬁed several splicing factors that
are members of the immunophilin family [14,16]. The inmuno-
philins represent a diverse group of proteins that are deﬁned by
their peptidyl-prolyl cis–trans isomerase (PPIase) activity and
are known to bind immunosuppressive drugs [17]. They cata-
lyze the conversion of proteins from cis to trans at Xaa-Pro
bonds, which is often a rate-limiting step in protein folding
and activity [18]. The ﬁrst of the immunophilins was isolated
in 1984 from bovine thymocytes as a molecule with high aﬃn-
ity for the immunosuppressive drug cyclosporin A (CsA) [19].
It was subsequently discovered that this protein also exhibits
PPIase activity [20]. The immunophilin superfamily is classiﬁed
into three major subfamilies, including the cyclosporin A
(CsA) binding proteins (cyclophilins or Cyps) [21], FK506
binding proteins (FKBPs) [22] and parvulins [23]. In addition,
other proteins bridge the two subfamilies by possession of both
cyclophilin and FKBP domains, like the one identiﬁed in the
protozoan, Toxoplasma gondii [24]. Immunophilins have been
documented in every Domain of the tree of life including
Archaea, Bacteria and Eukaryota and they are found in a
number of cellular compartments including the mitochondria,
endoplasmic reticulum, Golgi, nucleus and cytoplasm [17,25].blished by Elsevier B.V. All rights reserved.
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Fig. 1. An overview of pre-mRNA splicing. Removal of non-protein coding introns from pre-mRNA involves a dynamic, high molecular weight
complex known as the spliceosome. This nucleo-protein assemblage is comprised of ﬁve uridine rich small nuclear RNAs (snRNAs) as well as over
200 splicing proteins. All small nuclear ribonucleoprotein particles (snRNPs) (U1, U2, U4/U6 di-snRNP and U5) are labeled as they incorporate into
the spliceosomal complex. E1 and E2 represent exons, separated by an intron (line) containing the branch point sequence (symbolized by an A). The
names of each complex (E, A, B1, B2, C1, C2 and I) are designated in bold. ATP dependent reactions are indicated along the cycle. The degrading
intron is symbolized by a dashed line.
Table 1
Immunophilins of the spliceosome
Human immunophilin Putative yeast homologue Predicted size (kDa)
(Human/Yeast)
Known functional domains Interacting proteins
PPIH, Snu-Cyp20,
USA-Cyp, CypH
CYP3 (S. pombe) 19/19 Cyclophilin domain hPrp4, hPrp18
PPIG, SR-Cyp,
CARS-Cyp, CypG
– 89/– SR domain, Cyclophilin domain,
Nopp140 related domain
Clk/Sty, RNA polymerase II
PPIE, Cyp33, CypE – 33/– RRM, Cyclophilin domain hSAP49
PPIL1 CYP1 (S. pombe) 20/18 Cyclophilin domain 45S snRNP, 35S U5 snRNP,
SKIP, stathmin
PPIL2, Cyp60 Cyp60 (R. oryzae) 60/61 Ubox domain, Cyclophilin domain,
Uncharacterized conserved region
CD147, eglin C
PPIL3b, CypJ – 18/– Cyclophilin domain –
2346 A. Mesa et al. / FEBS Letters 582 (2008) 2345–2351All immunophilins possess at least one PPIase domain,
which modulates most of their cellular functions including
folding and chaperone activities [17,24]. A number of studies
have detected the presence of immunophilins in the nucleus.
These include PPIG [26], PPIE [27], PPIL1 [28], PPIH [29],
PPIL2 [16] and PPIL3a/PPIL3b [16]. These nuclear immuno-philins interact directly with splicing factors [29] and make
up part of the spliceosome. Some also bind to the carboxyl ter-
minal domain (CTD) of RNA polymerase II (RNA pol II)
[26]. The involvement of immunophilins in these processes
seems to be an ancient and universal trait due to their presence
in the splicing and transcriptional machinery in a multitude of
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Fig. 2. Potential functions of spliceosomal immunophilins in the mammalian cell. Based on the available data, the hypothesized entry and exit points
for each immunophilin into the spliceosome are delineated by arrows. In the cases of PPIL3b and PPIL2, dashed arrows are employed to indicate
unknown stages at which these proteins are incorporated into the spliceosome. In addition to their putative roles in splicing, these immunophilins
may modulate transcription regulation, microtubule assembly, folding and intra- and inter-cellular transport of proteins from the endoplasmic
reticulum and Golgi to locations like the cell membrane.
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identiﬁed cyclophilins in spliceosomal complexes (reviewed in
[30,31]). Interestingly, each of the analyses diﬀers in the num-
ber and types of cyclophilins that are found in the spliceosome
[31]. For example, Chen and coworkers [31] found six cyclo-
philins that co-purify with chicken spliceosomes (PPIE, PPIH,
serologically deﬁned colon cancer antigen 10 (SDCCAG10),
PPIL1, PPIL2 and peptidyl prolyl isomerase domain and
WD repeat containing 1 (PPWD1)). Rappsilber et al. [14] also
identiﬁed PPIL3b as part of the human spliceosome, as well as
all of the cyclophilins detected by Chen et al. [31] with the
exception of PPIH. Another analysis detected PPIE, CYP16,
PPIL1, PPIL2, PPIL3b and PPWD1 in human spliceosomes,
but not PPIH and SDCCAG10 [16]. The discrepancies among
the three studies may be related to species and/or tissue-speciﬁc
diversity in spliceosomal components. There is precedence for
tissue-speciﬁc variation in cyclophilin expression [32]. The dif-
ferences observed may also allude to the dynamic nature in
which these proteins associate with the spliceosome.
Given the constitutive and ubiquitous nature of RNA pro-
cessing, the presence of immunophilins in the splicing machin-
ery may be signiﬁcant in modulating spliceosomal activity. Anumber of spliceosomal immunophilins have been identiﬁed
in several taxa, including matrin-Cyp in Rattus norvegicus
[33] and AtCyp59 in Arabidopsis thaliana [34]. The overall
theme that emerges from our exploration of the literature is
that immunophilins are capable of catalyzing a number of
transport and foldase reactions that possibly assist in the
assembly/disassembly dynamics of the spliceosome as well as
in its coupling to the transcription machinery. Furthermore,
it is feasible that the capacity of immunophilins to alter folding
may provide accessibility and a mechanism for activating/inac-
tivating spliceosomal proteins. In this review, we focus on the
immunophilins of the human and yeast spliceosomes, as proto-
typic examples of the potential roles that immunophilins play
in splicing as well as in additional functions.
2. Spliceosomal immunophilins
2.1. PPIH associates with the hPrp4 and hPrp18 splicing factors
PPIH, also known as Snu-Cyp20, USA-Cyp or CypH in hu-
mans, is a 19 kDa nuclear protein that contains a single PPIase
domain and interacts speciﬁcally with the splicing factors
hPrp3, hPrp4 and hPrp18 [35–38] (Fig. 2, Table 1). Both hPrp3
2348 A. Mesa et al. / FEBS Letters 582 (2008) 2345–2351and hPrp4 are human splicing factors that integrate into the
U4/U6 di-snRNP and are essential for the initial steps of the
splicing reaction [39]. The hPrp18 splicing factor is involved
in the assembly of the U2/U6.U5 tri-snRNP and functions in
the second trans-esteriﬁcation reaction [40]. Horowitz et al.
[29] were able to elute complexes of [3H] CsA, His-tagged
PPIH and hPrp4 as well as [3H] CsA, His-tagged PPIH and
hPrp18 from aﬃnity columns. This ﬁnding suggests that inter-
actions between PPIH and either hPrp4 or hPrp18 do not dis-
rupt the active site for CsA binding [29]. In addition, the
crystal structure of PPIH [41] and PPIH in complex with a
peptide of hPrp4 [42] reveals that the active site of PPIH re-
mains free and maintains PPIase activity when bound to hPrp4
in vitro [42]. Taken together, these data indicate that the PPI-
ase domain of PPIH is available to aid in folding and/or trans-
port of other spliceosomal proteins. Horowitz et al. [29] also
found that PPIH is part of independent complexes with
hPrp3/hPrp4 and hPrp18, respectively and is involved in both
trans-esteriﬁcation steps of splicing as part of each unique
assembly. In addition, CsA inhibits both trans-esteriﬁcation
steps of pre-mRNA splicing in vitro and in vivo, an eﬀect that
Horowitz and colleagues attribute to the association of PPIH
with hPrp4 and hPrp18, respectively [29]. It is possible that
inhibition of splicing by CsA is via disruption of the PPIH
PPIase active site. Both hPrp4 and hPrp18 contain a highly
conserved region of 31 amino acids, which is the common
binding site for PPIH [42]. Horowitz et al. [29] propose that
PPIH mediates the proper folding and rearrangement of splice-
osomal components in the early steps of splicing through an
association with hPrp4 and indirectly, hPrp3 and may be in-
volved in chaperone activity or disassembly of the spliceosome
as a member of the hPrp18 complex. The fact that PPIH forms
independent complexes with two splicing factors may imply
that multiple PPIase substrates are present in the human splic-
ing machinery at diﬀerent times. It is well established that pep-
tidyl-prolyl cis–trans isomerization is a rate-limiting step in
protein folding, and it is feasible that the introduction of a
cyclophilin into the splicing machinery may contribute to the
eﬃciency of the splicing reaction. It is noteworthy that the pro-
tein with the highest amino acid identity to PPIH in Saccharo-
myces cerevisiae lacks the two regions diagnostic for the
protein at the N-terminus of the protein and the C-terminus
of helix 1 [42]. Interestingly, however, the presence of these re-
gions in the corresponding Cyps from a number of other spe-
cies including Homo sapiens, Mus musculus, Drosophila
melanogaster, Caenorhabditis elegans and Arabidopsis thaliana
as well as Schizosaccharomyces pombe and other fungi suggests
that these areas may have been deleted from the S. cerevisiae
orthologue. If these interactions are missing in S. cerevisiae,
the question remains whether PPIH is auxiliary or essential
to the splicing reaction, or whether one or more PPIases
substitutes for PPIH. The presence of multiple spliceosomal
immunophilins argues for a possible functional redundancy
in the splicing system.2.2. PPIG is a member of the transcription and splicing
machinery
Nestel et al. [32] demonstrated that PPIG (also known as
SR-Cyp, CARS-Cyp and CYPG in humans) interacts with
Clk/Sty in yeast two-hybrid screens. Clk/Sty is a member of
the SR protein kinase family involved in the regulation ofRNA splicing through phosphorylation of splicing factors
[43] (Fig. 2). PPIG was also identiﬁed as a nuclear matrix pro-
tein that assembles with splicing factors in nuclear speckles
[26], which are known to contain high concentrations of
RNA processing components [44]. Nestel et al. [32] identiﬁed
PPIG mRNAs in 13 human tissues and cell types, but could
not detect expressed transcripts corresponding to PPIG in nat-
ural killer (NK) cells, where the expression of the NK-TR1
cyclophilin is elevated [32]. Nestel et al. [32] postulated that
NK-TR1 performs the role(s) of PPIG in NK cells due to
the high sequence similarity among both proteins and the ab-
sence of PPIG in NK cells.
Bourquin et al. [26] showed that the SR domain of PPIG is
required for its interaction with the carboxyl terminal domain
(CTD) of RNA polymerase II. As a PPIase, PPIG may con-
tribute to the creation of a catalytically active form of RNA
polymerase II by folding the proline rich CTD [26] (Fig. 2).
Although the details of the transition between transcription
and splicing remain unknown, the participation of PPIG in
both pathways represents an example of the intimate connec-
tion between these two cellular functions. The coupling of
transcription and pre-mRNA splicing has been well docu-
mented [45]. A growing body of evidence indicates that tran-
scription and pre-mRNA splicing at the speckles on the
inner side of the nuclear membrane are structurally and func-
tionally linked, possibly for eﬃciency in facilitating transporta-
tion to the cytoplasm. Proteins like PPIG may represent a
mediator of these processes.
2.3. PPIE contains an RNA binding domain and is a part of the
human spliceosome
Mi et al. [27] initially detected PPIE (also known as Cyp33
and CypE in humans) in Jurkat human T-cell extracts utilizing
CsA aﬃnity columns as a cyclophilin with PPIase activity and
an RNA binding domain. Subsequent sequencing of cDNAs
with consensus cyclophilin domains led to the identiﬁcation
of the full-length PPIE gene [27]. This cyclophilin contains
an N-terminal RNA binding domain that is able to bind
poly(A) and poly(U) tracts of nucleic acid [27]. Western blots
also revealed that PPIE is exclusively present in nuclear frac-
tions [27]. Mi et al. [27] suggest that this protein may bind spe-
ciﬁc RNAs and aid in folding of additional RNA binding
proteins. More recently, two independent analyses of the hu-
man spliceosome using diﬀerent mass spectrometry techniques
identiﬁed PPIE as a member of the splicing machinery [16].
Consistent with the functions of a number of other immuno-
philins [32,29], PPIE may interact with the spliceosome to as-
sist in the proper folding and/or transport of splicing factors;
however, further work is needed to delineate the exact role(s)
that this protein plays in pre-mRNA splicing.
2.4. PPIL1 may catalyze folding of the 35S snRNP complex
PPIL1 is a 20 kDa cyclophilin with ubiquitous expression in
adult human tissues [46,47]. Recent studies using mass spec-
trometry have shown that PPIL1 is a component of the 45S
snRNP (B1) assemblage in active splicesosomes as well as an
element of the 35S U5 snRNP [48]. The 45S aggregate contains
all ﬁve UsnRNAs (U1, U2, U4, U5 and U6) and more than 60
pre-mRNA splicing factors [49]. The 35S U5 snRNP contains
a large number of proteins whose association facilitates the
formation of the B2 spliceosomal complex (Fig. 1) [50]. PPIL1
also binds the highly conserved transcription cofactor Ski
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with the Sloan-Kettering virus oncoprotein (SKI), an essential
member of histone deacetylase complexes (HDAC) and repres-
sor of transforming growth factor b (TGFb) signaling [52].
During splicing, SKIP is recruited before the ﬁrst catalytic
stage of splicing and remains bound through both trans-ester-
iﬁcation reactions [47]. PPIL1 is absent during B1 assembly,
where the U4/U6.U5 tri-snRNP ﬁrst comes together [50], but
it is incorporated during the formation of B2 (Fig. 2). Maka-
rov et al. [48] demonstrated that PPIL1 and SKIP also associ-
ate with the spliced intron as part of the 35S U5 snRNP. SKIP,
an indispensable spliceosomal component and transcriptional
coregulator [53], may regulate the eﬃciency of splicing by serv-
ing as a modulator of PPIL1 [3,51].
These data suggest that PPIL1 plays a role during the activa-
tion of the B2 spliceosomal complex as well as the removal of
the spliced intron (Fig. 2). During the transition from the inac-
tive B1 to an active B2 spliceosome that is poised to undertake
the ﬁrst trans-esteriﬁcation reaction, PPIL1 may be recruited by
SKIP in an interaction mediated by a region other than the PPI-
ase domain of PPIL1. This would enable the PPIase active site
of PPIL1 to remain open and facilitate folding of proline rich
members of the 45S snRNP [54]. PPIL1 may contribute to
the assembly and/or disassembly of the 45S snRNPs complex
in a manner similar to the other spliceosomal immunophilins
as a chaperone and/or folding enzyme. The presence of PPIL1
as part of the 35S complex also suggests that it may associate
with U5 snRNP and assist the release and subsequent disman-
tling of the 35S snRNP from the post-spliceosomal intron
(Fig. 2). The discovery that two cyclophilins (PPIG and PPIL1)
interact with both the splicing and transcription machinery al-
ludes to a potentially important role for these proteins in cou-
pling the processes of transcription and splicing. These PPIases
may bridge the two cellular functions by facilitating conforma-
tional changes and/or transporting proteins from the machin-
ery of transcription to that of the spliceosome.
2.5. PPIL2 and PPIL3b are components of the human
spliceosome
PPIL2 (also known as Cyp60 in humans and CYP60 in
yeast) is a 60 kDa human cyclophilin that is localized in both
the nucleus and cytoplasm [55]. Although its speciﬁc role has
yet to be elucidated, PPIL2 was identiﬁed as part of the human
spliceosome using liquid chromatography tandem mass spec-
trometry [16] and may serve as a chaperone or protein folding
enzyme much the same way as PPIH, PPIG, PPIE and PPIL1
(Fig. 2). Zhou et al. [56] identiﬁed cDNAs corresponding to
PPIL3b (also known as CypJ in humans) from a human fetal
brain cDNA library. The PPIL3b gene encodes an alterna-
tively spliced pre-mRNA that produces two isoforms, PPIL3a
and PPIL3b [56]. Thus far, only PPIL3b has been detected in
human spliceosomes [52]. Although its exact function is un-
known, PPIL3b is present in the B2 complex and absent in
B1, the U5 snRNP and the U4/U6.U5 tri-snRNP [31,48,50]
(Fig. 2). The lack of PPIL3b in the tri-snRNP and presence
in B2 suggests that it is part of the U2 snRNP complex.3. Conclusion
The current literature reveals that the spliceosomal immuno-
philins appear to mediate several functions in the removal ofintrons from pre-mRNA. First, as prolyl isomerases, they seem
to aid in folding and activation of proline containing splicing
factors, and may be essential in assembly/disassembly of splice-
osomal complexes, as well as in coupling transcription and
splicing. It remains to be determined whether the immunophi-
lins are essential for splicing reactions to take place, if they
possess a more auxiliary role in the splicing of particular tran-
scripts in diﬀerent tissues and/or developmental stages or both.
The identiﬁcation of immunophilins in such a ubiquitous
and universal assembly as the spliceosome may prompt us to
re-evaluate the mechanisms of action of CsA, FK506 and
other immunosuppressive drugs that interact with immunophi-
lins. For example, it is possible that some of the side eﬀects
resulting from treatments with CsA, FK506 or rapamycin
are brought about by sequestration and removal of immuno-
philins from the spliceosome. In fact, Horowitz et al. [29]
found that pre-mRNA splicing is inhibited by CsA in vitro
and in vivo. The association of drugs to immunophilins may
displace these proteins from the splicing complex and prevent
the creation of properly folded and active spliceosomes. Dis-
placement of immunophilins from the spliceosome may result
in fewer functional splicing complexes and a subsequent reduc-
tion in mature mRNAs necessary, for example, in cell cycle
control or immune system activation.
Understanding the exact function of the immunophilins in
splicing may lead to the creation of novel drugs that act by
sequestering an individual immunophilin from the spliceosome
at a particular time and/or tissue. It is clear that the highly con-
served nature of the PPIase domain hinders the development
of ligands that will bind a single immunophilin. Therefore, it
is important to target other domains of the immunophilins,
as well as unique loop regions between protein motifs. In this
way, therapeutic agents may be directed against single pro-
teins, rather than all members of a protein family. In addition,
it is possible that some of the antigenicity against spliceosomal
components in patients with autoimmune diseases resides in
the cyclophilins and further examination of the epitopes
responsible for these diseases is necessary. Unfortunately,
work describing spliceosomal immunophilins spans a period
of time between the mid-to late-1980s and continues only until
about 1998, after which the focus seems to have shifted to
other areas. Given the potential of these speciﬁc immunophi-
lins as possible drug receptors, further investigation is war-
ranted, speciﬁcally in relation to targetting immunophilins in
therapeutic strategies. Constant advances in molecular model-
ing, proteomics and synthetic chemistry are sure to help pave
the way for the development of unique and speciﬁc ligands.
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